Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 27, 2014Biochemical and Biophysical Research CommunicationsOpen Access

Protocadherin 9 inhibits epithelial–mesenchymal transition and cell migration through activating GSK-3β in hepatocellular carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

PZPengfei ZhuMerck & Co., Inc., Rahway, NJ, USA (United States)JLJun LvPreventive CardiologyZYZiwei YangNorth Sichuan Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhu et al. (2014) studied this question.

synapsesocial.com/papers/6a74174bb814d56a7d0a4cdbhttps://doi.org/10.1016/j.bbrc.2014.08.101
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Re-evaluation of the Carcinogenic Significance of Hepatitis B Virus Integration in Hepatocarcinogenesis2012 · 75 citations
  2. 2Protocadherin-19 and N-cadherin interact to control cell movements during anterior neurulation2010 · 115 citations